Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes.
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes.
复制标题
DOI:
10.1126/scitranslmed.3010643
复制
发表时间:
2014-12-03
影响因子:
17.1
通讯作者:
Kristie TM
中科院分区:
文献类型:
--
作者:
Hill JM;Quenelle DC;Cardin RD;Vogel JL;Clement C;Bravo FJ;Foster TP;Bosch-Marce M;Raja P;Lee JS;Bernstein DI;Krause PR;Knipe DM;Kristie TM
The high prevalence of Herpesviruses in the population and the maintenance of lifelong latent reservoirs are challenges to the control of herpetic diseases, despite the availability of antiviral pharmaceuticals that target viral DNA replication. In addition to oral and genital lesions, herpes simplex virus infections and recurrent reactivations from the latent pool can result in severe pathology including neonatal infection and mortality, blindness due to ocular keratitis, and viral-induced complications in immunosuppressed individuals. Herpesviruses, like their cellular hosts, are subject to the regulatory impacts of chromatin and chromatin modulation machinery that promotes or suppresses gene expression. The initiation of herpes simplex virus infection and reactivation from latency is dependent on a transcriptional coactivator complex that contains two required histone demethylases, LSD1 and JMJD2s. Inhibition of either of these enzymes results in heterochromatic suppression of the viral genome and a block to infection and reactivation in vitro. Here, the concept of epigenetic suppression of viral infection is demonstrated in three animal models of herpes simplex virus infection and disease. Inhibition of LSD1 via treatment of animals with the monoamine oxidase inhibitor tranylcypromine results in suppression of viral lytic infection, subclinical shedding, and reactivation from latency in vivo. Phenotypic suppression is correlated with enhanced epigenetic suppression of the viral genome and suggests that, even during latency, the chromatin state of the virus is dynamic. Given the expanding development of epipharmaceuticals, this approach has substantial potential for anti-herpetic treatments with distinct advantages over the present pharmaceutical options.
登录
查看更多内容
影响因子:
1.4
作者:
Duffus, WA;Mermin, J;Downing, R
通讯作者:
Downing, R
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
3.7
作者:
Creech, Clinton C.;Neumann, Donna M.
通讯作者:
Neumann, Donna M.
影响因子:
50.3
作者:
Chapuy B;McKeown MR;Lin CY;Monti S;Roemer MG;Qi J;Rahl PB;Sun HH;Yeda KT;Doench JG;Reichert E;Kung AL;Rodig SJ;Young RA;Shipp MA;Bradner JE
通讯作者:
Bradner JE
DOI:
10.1073/pnas.1406663111
发表时间:
2014-09-16
影响因子:
11.1
作者:
Hill, Alison L.;Rosenbloom, Daniel I. S.;Siliciano, Robert F.
通讯作者:
Siliciano, Robert F.